99 related articles for article (PubMed ID: 8851118)
21. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS
Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
24. Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
Cohen EE; Rosine D; Haraf DJ; Loh E; Shen L; Lusinchi A; Vokes EE; Bourhis J
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):678-84. PubMed ID: 17293229
[TBL] [Abstract][Full Text] [Related]
25. [Concomitant radiochemotherapy in locally advanced ORL cancers: a prospective study of 68 cases].
Maylin C; Walter S; Hennequin C; Brette MD; Durdux C; Monteil JP; Deboise A
Bull Cancer Radiother; 1996; 83(2):108-10. PubMed ID: 8688216
[TBL] [Abstract][Full Text] [Related]
26. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
27. High-dose cisplatin as neoadjuvant organ-preserving chemotherapy for squamous cell carcinoma of the larynx.
Lacava JA; Ferreyra R; Leone BA; Losada C; Elem YL; Vallejo CT
Cancer J Sci Am; 1996; 2(1):46-51. PubMed ID: 9166498
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of concomitant chemoradiation and surgical salvage for N3 nodal disease associated with upper aerodigestive tract carcinoma.
Ahmed KA; Robbins KT; Wong F; Salazar JE
Laryngoscope; 2000 Nov; 110(11):1789-93. PubMed ID: 11081585
[TBL] [Abstract][Full Text] [Related]
29. Neurotoxicity in a phase I trial of continuous infusion cisplatin with hyperfractionated radiotherapy for locally advanced head and neck cancer.
Clamon GH; Baatz L; Hoffman HT; Hussey DH; Glascock M; McCulloch TM; Graham SM
Head Neck; 1996; 18(3):236-41. PubMed ID: 8860764
[TBL] [Abstract][Full Text] [Related]
30. Incidence of isolated regional recurrence after definitive (chemo-) radiotherapy for head and neck squamous cell carcinoma.
Lambrecht M; Dirix P; Van den Bogaert W; Nuyts S
Radiother Oncol; 2009 Dec; 93(3):498-502. PubMed ID: 19766340
[TBL] [Abstract][Full Text] [Related]
31. [Simultaneous cisplatin and radiotherapy of locally advanced squamous cell carcinomas of the head and neck region. A clinical pilot study].
Higi M; Heuser L; Schmidt C; Grün D; Schettler D; Schmitt G
Dtsch Med Wochenschr; 1983 Nov; 108(46):1743-5. PubMed ID: 6685616
[TBL] [Abstract][Full Text] [Related]
32. Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.
Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T; Daimon T
Oral Oncol; 2007 Nov; 43(10):1014-20. PubMed ID: 17258494
[TBL] [Abstract][Full Text] [Related]
33. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
Adelstein DJ; Saxton JP; Rybicki LA; Esclamado RM; Wood BG; Strome M; Lavertu P; Lorenz RR; Carroll MA
J Clin Oncol; 2006 Mar; 24(7):1064-71. PubMed ID: 16505425
[TBL] [Abstract][Full Text] [Related]
34. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer.
Balm AJ; Rasch CR; Schornagel JH; Hilgers FJ; Keus RB; Schultze-Kool L; Ackerstaff AH; Busschers W; Tan IB
Head Neck; 2004 Jun; 26(6):485-93. PubMed ID: 15162349
[TBL] [Abstract][Full Text] [Related]
35. Advanced head and neck cancer: long-term results of chemo-radiotherapy, complications and induction of second malignancies.
Munker R; Purmale L; Aydemir U; Reitmeier M; Pohlmann H; Schorer H; Hartenstein R
Onkologie; 2001 Dec; 24(6):553-8. PubMed ID: 11799310
[TBL] [Abstract][Full Text] [Related]
36. Chemoradiotherapy with weekly cisplatin 40 mg/m(2) in 103 head-and-neck cancer patients: a cumulative dose-effect analysis.
Steinmann D; Cerny B; Karstens JH; Bremer M
Strahlenther Onkol; 2009 Oct; 185(10):682-8. PubMed ID: 19806334
[TBL] [Abstract][Full Text] [Related]
37. A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx.
Robbins KT; Fontanesi J; Wong FS; Vicario D; Seagren S; Kumar P; Weisman R; Pellitteri P; Thomas JR; Flick P; Palmer R; Weir A; Kerber C; Murry T; Ferguson R; Los G; Orloff L; Howell SB
Arch Otolaryngol Head Neck Surg; 1996 Aug; 122(8):853-7. PubMed ID: 8703389
[TBL] [Abstract][Full Text] [Related]
38. Severe reversible toxic encephalopathy induced by cisplatin in a patient with cervical carcinoma receiving combined radiochemotherapy.
Sterzing F; Grehn C; Dinkel J; Krempien R; Hartung G; Debus J; Harms W
Strahlenther Onkol; 2007 Sep; 183(9):487-9. PubMed ID: 17762922
[TBL] [Abstract][Full Text] [Related]
39. Complications associated with selective high-dose intraarterial cisplatin and concomitant radiation therapy for advanced head and neck cancer.
Gemmete JJ
J Vasc Interv Radiol; 2003 Jun; 14(6):743-8. PubMed ID: 12817041
[TBL] [Abstract][Full Text] [Related]
40. Stages III and IV squamous cell carcinoma of the mouth: three-year experience with superselective intraarterial chemotherapy using cisplatin prior to definitive treatment.
Hirai T; Korogi Y; Hamatake S; Nishimura R; Baba Y; Takahashi M; Uji Y; Taen A
Cardiovasc Intervent Radiol; 1999; 22(3):201-5. PubMed ID: 10382049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
